In vitro blastogenesis of equine lymphocytes by inactivated equine adenovirus type 1 antigen.

This study investigates the immune response of horses when vaccinated with an inactivated equine adenovirus type 1 (EAdV1) and the subsequent effect on lymphocyte blastogenesis (LB), a crucial immune response. The vaccinated horses developed higher virus-neutralizing (VN) antibodies, indicating an increased immune response to the EAdV1 antigen.

Research Methodology

• The research was conducted on six horses, four of which were vaccinated with inactivated EAdV1 and the other two were left as non-vaccinated control subjects.
• The vaccinated horses initially had VN antibodies but developed higher VN antibody titers as a result of the vaccination.
• The control horses, on the other hand, showed no increase in VN antibodies, establishing that the observed increase in the vaccinated horses was solely due to the vaccine and not an external EAdV1 outbreak during the course of the study.
• Horses were vaccinated at the start of the study and two weeks later. LB assays were conducted ten times over a month, four days before the initial vaccination and then every three to four days until the end of the study.

Results and Interpretations

• For the LB tests, lymphocytes from the horses were exposed to two different concentrations of the inactivated EAdV1 antigen for four days.
• The control horses did not demonstrate any significant changes in their LB responses throughout the study, with their highest stimulation indices ranging from 2.8 to 3.6 when exposed to the EAdV1 antigen.
• Conversely, the vaccinated horses displayed a pronounced increase in their stimulation indices (5.3 to 18.6) upon exposure to the EAdV1 antigen, indicating a strong immune response post the vaccination.
• As another control measure, lymphocytes from all horses were also exposed to phytohemagglutinin, and they all responded in a normal fashion, reinforcing the fact that the altered LB response was specifically due to the EAdV1 antigen and the effect of the vaccination.

Upon evaluation, the study shows that an inactivated EAdV1 vaccine can effectively stimulate a robust immune response in vaccinated horses, as illustrated by the increased blastogenesis of lymphocytes. The response to other antigens remains unaffected, highlighting the specificity of the vaccine-induced immune response. Further research is required to replicate these results and potentially develop effective vaccinations against equine adenoviruses.